Pharmacokinetics of Moxifloxacin in an Infant With Mycoplasma hominis Meningitis

Authors:

Abstract
Treatment of Mycoplasma hominis meningitis in infants is limited by a lack of consensus regarding therapy and limited pharmacokinetic data for agents to which M. hominis is susceptible. We report the successful treatment of a premature infant suffering from M. hominis meningitis with doxycycline and moxifloxacin and provide a pharmacokinetic profile of moxifloxacin.

This publication has 10 references indexed in Scilit: